Name: Myocardial Tissue Engineering (en Inglés)
Price: 2181.33 MXN
Availability: InStock
Author: Shimizu, Tatsuya ; Matsuura, Katsuhisa
ISBN: 9789814411318

Envío gratis

portada Myocardial Tissue Engineering (en Inglés)

Formato

Libro Físico

Editorial

Jenny Stanford Publishing

Autor

Shimizu, Tatsuya ; Matsuura, Katsuhisa

Idioma

Inglés

N° páginas

252

Encuadernación

Tapa Dura

Dimensiones

23.1 x 15.7 x 2.3 cm

Peso

0.46 kg.

ISBN13

9789814411318

Categorías

Ciencias básicas de la medicina preclínica
Enfermedades cardiovasculares
Biología
Biotecnología

Myocardial Tissue Engineering (en Inglés)

Shimizu, Tatsuya ; Matsuura, Katsuhisa (Autor) · Jenny Stanford Publishing · Tapa Dura

Libro Nuevo

$ 2,181.33

$ 4,362.67

Ahorras: $ 2,181.33

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 21 de Junio y el Miércoles 03 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Myocardial Tissue Engineering (en Inglés)"

Regenerative therapy has rapidly developed as one of the most promising treatments for patients suffering from severe heart failure. Autologous bone marrow-derived cells and cardiac stem cells have been clinically applied for cell injection therapy for heart failure. As a next-generation therapy, tissue-engineered myocardial-patch transplantation has also been started clinically. As further advanced therapy, several researchers have started to fabricate three-dimensional beating myocardial tissues. One of the main problems in myocardial tissue engineering is neovascularization within the tissues during scale-up. Several innovative technologies have been developed to overcome the vascularization problem.This book broadly summarizes myocardial tissue engineering and regenerative medicine, which consists of myocardial cell sources, cell therapy for damaged hearts, and tissue engineering technologies for fabricating beating hearts. With respect to myocardial cell source, it focuses on cardiac cells differentiated from embryonic stem and induced pluripotent stem cells. It describes the remarkable results obtained in the past and the present to control neovascularization and presents the future challenges in myocardial tissue engineering research.